Medicamen Biotech Ltd.
Snapshot View

View in App

Prices View details >>

645.70 +21.60 ▲3.5%

22 March 2023, 03:49:14 PM
Volume: 21,316

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.medicamen.com
Market Cap 810.11 Cr.
Enterprise Value(EV) 787.62 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 10.83 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 59.13 Trailing Twelve Months Ending 2022-12
Industry PE 31.70 Trailing Twelve Months Ending 2022-12
Book Value / Share 142.68 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.49 Calculated using Price: 640.35
Dividend Yield 0.16 Period Ending 2022-03
No. of Shares Subscribed 1.27 Cr. 12,651,100 Shares
FaceValue 10
Company Profile
Medicamen Biotech Limited was incorporated in December 1993, it is a widely held, Globaly Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. Medicamen Biotech Limited is committed to produce and provide quality medicines at competitive price for domestic as well as international markets thereby being socially responsible and rendering services to the medical fraternity since inception.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+3.46%
1 Week
+4.60%
1 Month
-4.60%
3 Month
-20.52%
6 Month
-40.71%
1 Year
-5.52%
2 Year
5 Year
10 Year

Ratios View Details >>

4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 13.95 12.94 9.89 11.24
Return on Capital Employed (%) 19.30 16.54 12.99 12.94
Return on Assets (%) 8.80 8.36 6.46 7.11

Balance Sheet View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 87 121 133 146 186
Non Curr. Liab. 1 4 8 6 2
Curr. Liab. 49 56 53 73 70
Minority Int.
Equity & Liab. 137 181 194 225 258
Non Curr. Assets 40 75 91 94 105
Curr. Assets 96 104 96 123 153
Misc. Exp. not W/O 0 2 7 8
Total Assets 137 181 194 225 258

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 123 126 113 115 125
Other Income 4 2 1 2 2
Total Income 126 127 113 117 127
Total Expenditure -105 -106 -93 -91 -103
PBIDT 21 21 20 26 25
Interest -1 -1 -2 -2 -3
Depreciation -2 -3 -3 -6 -6
Taxation -6 -5 -4 -3 -2
Exceptional Items
PAT 12 13 12 15 14
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 12 13 12 15 14
Adjusted EPS 10 11 10 12 11

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 13 13 4
Cash Fr. Inv. -15 -37 -18 -8
Cash Fr. Finan. -4 19 6 4
Net Change -14 -5 1 0
Cash & Cash Eqvt 9 3 4 4

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 44.77 44.83 44.83 44.83 43.60 43.60 43.60 43.21 43.21
Public 55.23 55.17 55.17 55.17 56.40 56.40 56.40 56.79 56.79
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 21 Mar 2023
Trading Window
Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Fri, 03 Mar 2023
Loss of Share Certificates
Medicamen Biotech Limited has informed the Exchange about Loss of Share Certificates
Tue, 14 Feb 2023
Copy of Newspaper Publication
Medicamen Biotech Limited has informed the Exchange about Copy of Newspaper Publication

Technical Scans View Details >>

Tue, 21 Mar 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months
William %R Bullish William %R Bullish

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,474.95 +1.3%
Divi's Laboratories Ltd. 73,553.38 2,790.65 +0.8%
Cipla Ltd. 69,632.88 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. 51,277.87 1,518.60 +0.2%
Zydus Lifesciences Ltd. 48,378.30 478.65 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-12 26.39 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 478.65 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-12 3.07 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 478.65 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 478.65 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.65 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 478.65 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 478.65 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.05 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,474.95 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,790.65 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 863.40 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,285.10 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.60 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 478.65 +0.1%

FAQ's On Medicamen Biotech Ltd.

What is Medicamen Biotech share price?
Can I buy Medicamen Biotech shares now?
What is the Dividend Yield of Medicamen Biotech?
What is the Market Cap of Medicamen Biotech?
What are the key metrics to analyse Medicamen Biotech?
What is the 52 Week High and Low of Medicamen Biotech?
What is the trend of Medicamen Biotech share price?